Table 2 Clinical presentation.
| EA group (n=6) | LA group (n=11) | P value | ||
|---|---|---|---|---|
| Duration for developing graft infection (months) | 59.1 (0.4–100.7) | 99.8 (2.6–29.4) | 0.28 | |
| Prosthetic graft | Dacron 6 (100%) | Dacron 11 (100%) | — | |
| Infection site | Peripheral | 5 (83.3%) | 9 (81.8%) | 0.94 |
| Abdominal | 1 (16.7%) | 2 (18.2%) | ||
| Microorganism | Antibiotic resistant | 3 (50.0%) | 3 (27.3%) | 0.34 |
| Laboratory data | WBC >9,000 or <4,000/mL | 3 (50.0%) | 8 (72.7%) | 0.35 |
| CRP (mg/dL) | 10.5±13.6 | 9.2±9.6 | 0.81 |
EA: early antibiotic; LA: late antibiotic; CRP: C-reactive protein; WBC: white blood cells